ArticleHaematologica2022

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase.

Burcu Aslan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.